Anhui Gujing Group Co.Ltd is set upwith the Anhui Gujing Gongjiu holdings Co.Ltd(formerly the Gujing Distillery) as a coreenterprise.The group company is alsofounded on the basis of Anhui Gujing IndustryGroup,one of t...Anhui Gujing Group Co.Ltd is set upwith the Anhui Gujing Gongjiu holdings Co.Ltd(formerly the Gujing Distillery) as a coreenterprise.The group company is alsofounded on the basis of Anhui Gujing IndustryGroup,one of the seven enterprise groupswith plans directly under the provincialauthorities.The group company has beenreorganized into the present one according tointernational practice.It is a state-ownedenterprise with a registered capital ofRMB527.73 million,and has 20 subsidiarycompanies. The group company is engaged inliquor production and sales。展开更多
Objective:Our goal was to examine the impact of Zhuangshen Gujing decoction on proteinuria associated with chronic nephritis.Methods:72 patients with chronic nephritis proteinuria were divided randomly into two groups...Objective:Our goal was to examine the impact of Zhuangshen Gujing decoction on proteinuria associated with chronic nephritis.Methods:72 patients with chronic nephritis proteinuria were divided randomly into two groups;one group was treated with Zhuangshen Gujing(n=36;treatment group)and the other group was treated with irbesartan(n=36;control group).After 6 months’treatment,urine protein and renal function were evaluated.Results:Proteinuria resolved completely in four patients in the treatment group;complete disease resolution was observed only among three individuals in the control group.Of the 32 cases remaining in the treatment group,15 had substantial responses to Zhuangshen Gujing decoction,9 had partial responses,and 8 had no response to treatment;the overall the response rate was 73.33%.Among the 33 cases remaining in the control group,12 had a substantial response to irbesartan,5 had a partial response,and 16 had no response to treatment;the overall response rate among the controls was 57.67%(P=0.031).We also observed statistically significant differences with respect to quantitative comparisons of urinary protein at 24 days after a single course of treatment(P=0.001).Conclusion:Zhuangshen Gujing decoction is effective in treating chronic nephritis proteinuria.展开更多
文摘Anhui Gujing Group Co.Ltd is set upwith the Anhui Gujing Gongjiu holdings Co.Ltd(formerly the Gujing Distillery) as a coreenterprise.The group company is alsofounded on the basis of Anhui Gujing IndustryGroup,one of the seven enterprise groupswith plans directly under the provincialauthorities.The group company has beenreorganized into the present one according tointernational practice.It is a state-ownedenterprise with a registered capital ofRMB527.73 million,and has 20 subsidiarycompanies. The group company is engaged inliquor production and sales。
文摘Objective:Our goal was to examine the impact of Zhuangshen Gujing decoction on proteinuria associated with chronic nephritis.Methods:72 patients with chronic nephritis proteinuria were divided randomly into two groups;one group was treated with Zhuangshen Gujing(n=36;treatment group)and the other group was treated with irbesartan(n=36;control group).After 6 months’treatment,urine protein and renal function were evaluated.Results:Proteinuria resolved completely in four patients in the treatment group;complete disease resolution was observed only among three individuals in the control group.Of the 32 cases remaining in the treatment group,15 had substantial responses to Zhuangshen Gujing decoction,9 had partial responses,and 8 had no response to treatment;the overall the response rate was 73.33%.Among the 33 cases remaining in the control group,12 had a substantial response to irbesartan,5 had a partial response,and 16 had no response to treatment;the overall response rate among the controls was 57.67%(P=0.031).We also observed statistically significant differences with respect to quantitative comparisons of urinary protein at 24 days after a single course of treatment(P=0.001).Conclusion:Zhuangshen Gujing decoction is effective in treating chronic nephritis proteinuria.
